Meeting report VLPNPV: Session 6: Development and characterization.

who, world health organization im, intramuscular ms2 hiv, human immunodeficiency virus apc, antigen presenting cells cge, capillary gel electrophoresis clp, core-like particle gfp, green fluorescent protein h7n9 ha, hemagglutinin hai, hemagglutination-inhibition hbcag hbcag, hepatitis b core antigen il-1β, interleukin 1β iga/igg, immunoglobulin a/immunoglobulin g na, neuraminidase niv, nipah virus nov, norovirus rv vp6 rv, rotavirus s. aureus, staphylococcus aureus sf9, spodoptera frugiperda 9 vlp vlp, virus-like particle vp2/vp6, viral protein 2/viral protein 6 cgmp, current good manufacturing practices hmts, hollow microstructured transdermal system mrna, messenger rna smts, solid microstructured transdermal system